Logo image of FCUV

FOCUS UNIVERSAL INC (FCUV) Stock Fundamental Analysis

NASDAQ:FCUV - Nasdaq - US34417J2033 - Common Stock - Currency: USD

3.6  -0.08 (-2.31%)

After market: 3.69 +0.09 (+2.5%)

Fundamental Rating

2

Taking everything into account, FCUV scores 2 out of 10 in our fundamental rating. FCUV was compared to 125 industry peers in the Electronic Equipment, Instruments & Components industry. The financial health of FCUV is average, but there are quite some concerns on its profitability. FCUV is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year FCUV has reported negative net income.
In the past year FCUV has reported a negative cash flow from operations.
FCUV had negative earnings in each of the past 5 years.
In the past 5 years FCUV always reported negative operating cash flow.
FCUV Yearly Net Income VS EBIT VS OCF VS FCFFCUV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

FCUV has a Return On Assets of -166.89%. This is amonst the worse of the industry: FCUV underperforms 96.80% of its industry peers.
FCUV has a worse Return On Equity (-234.52%) than 93.60% of its industry peers.
Industry RankSector Rank
ROA -166.89%
ROE -234.52%
ROIC N/A
ROA(3y)-73.26%
ROA(5y)-57.64%
ROE(3y)-98.92%
ROE(5y)-74.84%
ROIC(3y)N/A
ROIC(5y)N/A
FCUV Yearly ROA, ROE, ROICFCUV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K

1.3 Margins

Looking at the Gross Margin, with a value of 6.93%, FCUV is doing worse than 86.40% of the companies in the same industry.
FCUV's Gross Margin has declined in the last couple of years.
FCUV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 6.93%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-50.39%
GM growth 5Y-20.79%
FCUV Yearly Profit, Operating, Gross MarginsFCUV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

More info and screens

6

2. Health

2.1 Basic Checks

FCUV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, FCUV has more shares outstanding
FCUV has more shares outstanding than it did 5 years ago.
FCUV has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
FCUV Yearly Shares OutstandingFCUV Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
FCUV Yearly Total Debt VS Total AssetsFCUV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M

2.2 Solvency

FCUV has an Altman-Z score of -2.44. This is a bad value and indicates that FCUV is not financially healthy and even has some risk of bankruptcy.
FCUV has a worse Altman-Z score (-2.44) than 86.40% of its industry peers.
There is no outstanding debt for FCUV. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -2.44
ROIC/WACCN/A
WACC8.89%
FCUV Yearly LT Debt VS Equity VS FCFFCUV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M 10M

2.3 Liquidity

A Current Ratio of 3.25 indicates that FCUV has no problem at all paying its short term obligations.
FCUV has a Current ratio of 3.25. This is in the better half of the industry: FCUV outperforms 65.60% of its industry peers.
FCUV has a Quick Ratio of 3.17. This indicates that FCUV is financially healthy and has no problem in meeting its short term obligations.
FCUV's Quick ratio of 3.17 is fine compared to the rest of the industry. FCUV outperforms 76.80% of its industry peers.
Industry RankSector Rank
Current Ratio 3.25
Quick Ratio 3.17
FCUV Yearly Current Assets VS Current LiabilitesFCUV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for FCUV have decreased strongly by -133.11% in the last year.
The Revenue for FCUV has decreased by -43.42% in the past year. This is quite bad
The Revenue for FCUV have been decreasing by -22.89% on average. This is quite bad
EPS 1Y (TTM)-133.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.18%
Revenue 1Y (TTM)-43.42%
Revenue growth 3Y-34.7%
Revenue growth 5Y-22.89%
Sales Q2Q%-13.18%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
FCUV Yearly Revenue VS EstimatesFCUV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

FCUV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
FCUV Price Earnings VS Forward Price EarningsFCUV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
FCUV Per share dataFCUV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

FCUV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FOCUS UNIVERSAL INC

NASDAQ:FCUV (6/13/2025, 8:00:02 PM)

After market: 3.69 +0.09 (+2.5%)

3.6

-0.08 (-2.31%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)05-13 2025-05-13
Earnings (Next)08-12 2025-08-12
Inst Owners2.89%
Inst Owner Change-91.13%
Ins Owners55.32%
Ins Owner Change0%
Market Cap25.63M
Analysts0
Price TargetN/A
Short Float %3.45%
Short Ratio3.28
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 43.56
P/FCF N/A
P/OCF N/A
P/B 13.5
P/tB 13.5
EV/EBITDA N/A
EPS(TTM)-0.61
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.71
FCFYN/A
OCF(TTM)-0.7
OCFYN/A
SpS0.08
BVpS0.27
TBVpS0.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -166.89%
ROE -234.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 6.93%
FCFM N/A
ROA(3y)-73.26%
ROA(5y)-57.64%
ROE(3y)-98.92%
ROE(5y)-74.84%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-50.39%
GM growth 5Y-20.79%
F-Score5
Asset Turnover0.22
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 84.7%
Cap/Sales 6.31%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3.25
Quick Ratio 3.17
Altman-Z -2.44
F-Score5
WACC8.89%
ROIC/WACCN/A
Cap/Depr(3y)20.4%
Cap/Depr(5y)14.74%
Cap/Sales(3y)6.93%
Cap/Sales(5y)4.44%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-133.11%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%17.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-43.42%
Revenue growth 3Y-34.7%
Revenue growth 5Y-22.89%
Sales Q2Q%-13.18%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-48.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71.98%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-71.89%
OCF growth 3YN/A
OCF growth 5YN/A